# The Angel® Catheter Pivotal Clinical Trial

Study · id `cardio:ct-nct02186223` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT02186223](<https://clinicaltrials.gov/study/NCT02186223>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT02186223

Browse, organ or system: Heart; Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 172 participants.

## Technical summary

Registry record NCT02186223. Allocation not applicable; no masking; primary purpose prevention. Start 2015-01 (actual); primary completion 2015-12 (actual). Results posted on 2017-04-04.

## Key facts

- Design: Interventional study; allocation not applicable; no masking; primary purpose prevention
- Phase: Not applicable
- Enrolled: 172 participants (enrolled count; ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Started: 2015-01 (actual) (ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Primary completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Completion: 2015-12 (actual) (ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Results first posted: 2017-04-04 (ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT02186223, source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "COMPLETED" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct02186223-2017-04-04`, retrieved 2026-10-31)

## The registry's words

- Brief title: The Angel® Catheter Pivotal Clinical Trial
- Condition: Pulmonary Embolism
- Condition: Deep Vein Thrombosis
- Condition: Venous Thromboembolism
- Condition: Trauma
- Intervention (Device): The Angel® Catheter
- Lead sponsor: BiO2 Medical
- Lead sponsor class: INDUSTRY
- Collaborator: CardioMed Device Consultants, LLC
- Collaborator class: INDUSTRY
- Collaborator: Intrinsic Imaging, LLC
- Collaborator class: UNKNOWN
- Collaborator: Novella Clinical
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Deep vein thrombosis (`cardio:deep-vein-thrombosis`)
- Registry condition terms include this condition: Pulmonary embolism (`cardio:pulmonary-embolism`)
- Registry lists this organization as a collaborator: CardioMed Device Consultants, LLC (`cardio:org-cardiomed-device-consultants-llc`)

## Provenance

Content hash: 0d6130d861d6b36e5b3dea5c8e06bcada76129986424841f0ecbf902072d9a05
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
